UNLIMITED TURBO BULL - AMGEN | Market Closed - Euronext Paris 10:00:00 03/06/2024 pm IST | ||
| 11.32 EUR | +0.89% |
|
| Current month | +0.89% | ||
| 1 month | -7.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 11.32 | +0.89% |
| 31/24/31 | 11.22 | +3.99% |
| 30/24/30 | 10.79 | +1.03% |
| 29/24/29 | 10.68 | -1.75% |
| 28/24/28 | 10.87 | -5.56% |
Real-time Euronext Paris
Last update June 03, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| 8C37S | |
| ISIN | DE000SU96G03 |
| Date issued | 04/03/2024 |
| Strike | 183.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.79 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.62 € |
|---|---|
| Lowest since issue | 7.5 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.88%
- Stock Market
- Certificates
- 8C37S Certificat
